Merck News, Merck Quote, MRK Quote

Merck (NY:MRK) Delayed: 128.58 +0.21 (0.16%)

Prev. Close

$128.37

Today 6M 1Y 5Y

Open

$127.84

52 Wk High

$65.46

52 Wk Low

$47.97

Day High

$128.75

Day Low

$126.68

P/E

87.47

EPS

$1.47

Volume

7,349,252

Friends, Peers and Foes (?): MKKGY, LLY, PFE, GILD, TERN (more...)

ALERTS | RSS

Aug 7, 2026 04:22 PM Form 4 Merck & Co., Inc. For: Aug 05 Filed by: Maraldo David R.
Aug 7, 2026 04:21 PM Form 4 Merck & Co., Inc. For: Aug 05 Filed by: Williams David Michael
Aug 7, 2026 04:19 PM Form 4 Merck & Co., Inc. For: Aug 06 Filed by: Guindo Chirfi
Aug 7, 2026 04:13 PM Form 10-Q Merck & Co., Inc. For: Jun 30
Aug 7, 2026 04:05 PM Form 13F-HR Merck & Co., Inc. For: Jun 30
Aug 6, 2026 04:47 PM Form 144 Merck & Co., Inc. Filed by: Guindo Chirfi
Aug 6, 2026 04:45 PM Form 144 Merck & Co., Inc. Filed by: DeLuca Richard R.
Aug 6, 2026 04:36 PM Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
Aug 6, 2026 06:45 AM FDA accepts Merck's sBLA for Enflonsia to cover second RSV season
Aug 6, 2026 06:45 AM U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Ri

Entities mentioned with MRK

View All Entities